Background:
Introduction
Cl inical trials in the field of diabetes management (as well as other therapeutic areas) are increasingly being designed to include data collected directly from patients and require the use of some form of diary, either paper or electronic (e-diaries). These diaries are designed to capture various aspects of the patient's therapeutic experience, including frequency and severity of disease symptoms, treatment outcomes, and impact of the disease and/or treatment on everyday activities and overall quality of life.
1 In particular, patients with diabetes are often asked to track numerous parameters of disease management, such as blood glucose levels, dietary intake, and activity levels. 2 Possible advantages of e-diaries versus traditional paper diaries include the potential for improved patient compliance and reductions in practices such as parkinglot compliance (filling in the entire diary immediately prior to the study visit) or forward filling (entering data prior to the scheduled time). 1, [3] [4] [5] In a study of 84 adults with chronic pain, Stone and colleagues 4 used a paper diary system equipped with a mechanism to electronically record the time and date that the diary binder was actually opened and closed. The authors observed that patients submitted paper entries reported as occurring within 15 minutes of assigned times with 90% compliance, whereas the actual (electronically recorded) compliance was only 11%. Overall, 75 to 80% of the times and dates of paper diary entries in this study were shown to be falsified. 4 E-diaries have builtin mechanisms for addressing these types of behaviors, such as time stamping of all entries and automatic alarm reminders. 2 In the study by Stone and colleagues, actual compliance with an e-diary system was 94%. 4 The use of e-diaries has also been shown to reduce missing data values in questionnaires. For example, in a study of 60 children aged 8 to 16 years with recurrent pain, e-diaries were significantly more accurate than paper diaries (100% versus 51% of diaries were returned with no errors or omissions, p < 0.001). 3 In a 1-year ediary validation study (N = 36 patients with chronic low back pain), patients using an e-diary demonstrated nearly 90% compliance with daily monitoring, entering data on average 6.75 times per week. Correlations with paper diary entries, phone reports, and other measures indicated that data from e-diaries were both reliable and valid. 5 In addition, e-diaries may allow speedier and more accurate handling of data, including faster time to analysis and reduced data management workload.
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Some of these benefits, however, may depend on the particular type of e-diary selected for a clinical trial. The e-diary systems offered by different vendors can vary in a number of ways: the type of palm device provided to patients, the form and quality of technical support available, the frequency of technical problems that arise during routine use, the Web site for storing and retrieving uploaded patient data, and the overall userfriendliness of the e-diary tools provided by the vendor. Because of these important differences, a survey was conducted involving clinical site coordinators who had participated in several different diabetes clinical trials utilizing different e-diary systems for data collection. The objectives of this study were the following: to identify features of e-diary systems that are important to consider in the design of future diabetes clinical trials, particularly those that simplify use; to understand how to improve clinical trial management with e-diaries; and to assess possible effects of e-diary utilization on clinical trial factors such as patient enrollment and patient training.
Methods
A total of four diabetes clinical trials were identified that used e-diary systems provided by three different vendors (henceforth referred to as systems A, B, and C). Each e-diary system was contained on a personal digital assistant (PDA) device on which all other features had been disabled. Patients could either input data manually or send information electronically from their glucose meters. Data from each PDA device were transmitted to a central database for later analysis via phone or through a docking station. A survey containing 42 questions and estimated to require 15 to 20 minutes to complete was distributed via the Internet to site coordinators participating in these four clinical trials. Survey questions covered areas such as the site coordinators' characteristics, e-diary design and features, and the experience of the site coordinators with any ediary technical issues. All of the survey questions were close ended and of the 42 total questions, 5 pertained to background characteristics and 37 involved rating the e-diary system. For example, the individual items of the survey consisted of questions such as "How long have you been a study coordinator?" (0-2 years, 2-4 years, or 5+ years), whether "The e-diary ran out of memory so that data could not be stored on the device" (often, sometimes, seldom, or never), and if "The text on the screen of the e-diary was easy-to-read for elderly patients" (strongly agree, agree, disagree, strongly disagree, or N/A). The complete survey may be found in the Appendix.
Clinical Trials
The four clinical trials included in this survey of ediary technology are ongoing (currently unpublished) phase 3 or phase 4 studies with differing patient populations, study designs, and treatment regimens for type 2 diabetes mellitus. The e-diary system used in each clinical trial is tailored to the parameters being evaluated in each study. For example, the e-diary used for one trial may collect data on diabetes treatment satisfaction, whereas the e-diary used for another trial may collect data on the amount of daily physical activity in diabetes patients. Thus, each e-diary is designed to capture the most relevant data for a given clinical trial. It is important to note, however, that all of these trials included adults aged 18 to 65 years with type 2 diabetes mellitus who had failed to reach glycemic goals with oral antidiabetic medications alone and were initiated on insulin therapy. So as to more easily compare among the different e-diaries, this analysis was confined to e-diaries used only in clinical trials for diabetes, and therefore have some very important parameters in common. For instance, all of the e-diaries examined in this study collected data pertaining to patient blood glucose levels, insulin dose and titration, food intake, quality of life, and adverse events, particularly the number of hypoglycemic events.
Survey Development and Distribution
Initially, interviews and focus groups were conducted with site coordinators, study managers, and e-diary vendors to determine which issues related to e-diary use were most important to address and to solicit ideas for questionnaire development. Specifically, the survey addressed the following topics: the background experience of the site coordinator; the technical capabilities of the e-diary system used (e.g., memory capacity, ease of data upload, and ease of Web site navigation); the overall design and features of the system; overall satisfaction with the system; and perceived utility of the e-diary in clinical studies. A draft survey was then circulated to study managers and data managers to elicit feedback, after which a finalized version was distributed to 295 site coordinators from four diabetes clinical trials. Thus, while study managers and data managers, who oversee the clinical trial as a whole across all study sites, provided feedback on the content of the draft survey, site coordinators, who are responsible for the conduct of the study at the local level, completed the final survey. To be eligible to participate, site coordinators must have had experience with e-diary utilization in at least one diabetes clinical trial. Site coordinators who had e-diary experience in more than one trial were asked to complete a separate questionnaire for each trial. Surveys were distributed via the Internet using Zoomerang.com and site coordinators were given one month to complete the online survey.
Survey Analysis
The final survey consisted of 42 individual items organized into six different sections entitled background information, e-diary technical issues, e-diary design and features, study parameters, global rating, and general considerations. Site coordinators were asked to provide a global satisfaction rating of the e-diary technology: "On a scale from 1 (lowest) to 10 (highest), how would you rate your overall experience with this e-diary?" Survey analysis consisted of calculating correlations between individual items and the global satisfaction rating to determine which e-diary features were most closely associated with site coordinators' overall ediary experience. An analysis was also performed to assess differences among the three e-diaries in global satisfaction rating, background experience of site coordinators with each system, responses to technical issues with the e-diary, and questions regarding the user-friendliness of the e-diary data-management Web site. Differences were then compared among the different e-diary systems for the individual survey items, particularly items pertaining to the usefulness and accuracy of the e-diary-in the opinion of site coordinators-as a tool to capture specific types of data (i.e., quality of life, food intake, blood glucose levels, dose titration of insulin, and drug utilization). These comparisons were conducted using analysis of variance and the Kruskal-Wallis (nonparametric) test.
Results
The survey was distributed to 295 site coordinators and completed by 131, for an overall response rate of 44%. There were no meaningful differences in study coordinator background characteristics. Individual survey items with the highest correlation with the e-diary global satisfaction rating are listed in Table 1 . In general, the highest correlations were related to (1) technical problems not easily resolved (i.e., those requiring a call to a help line, requiring a new device, or resulting in loss of data that the patient had input), (2) the organization and ease of navigating through the e-diary Web site, and (3) the ability of the help line service to answer questions and fully resolve any problems. In addition, the site coordinator's belief that the e-diary was a good tool to capture quality-of-life and food intake data also correlated highly with the global satisfaction rating. In contrast, items that were not significantly correlated with the global satisfaction rating were the site coordinators' experience with ediary use in previous studies, the number of years of job experience as a site coordinator, and different age groups willing to participate in a clinical trial utilizing an e-diary (i.e., use of an e-diary had no impact on recruitment of elderly patients). Figure 1 shows responses to several individual e-diary survey questions that were most highly correlated with e-diary global satisfaction rating. These responses are shown for overall survey respondents (N = 131) and were broken down according to each specific e-diary system (system A, trial 1, n = 40; system B, trial 2, n = 36; system C, trial 3, n = 26; system C, trial 4, n = 29). There were considerable differences among responses for the various e-diary systems. Therefore, the three e-diary systems were compared using the Kruskal-Wallis test to identify significant differences in mean global satisfaction rating and responses to individual survey items ( Table 2) . Mean global satisfaction rating varied from a high score of 7.2 (1-10 scale) for system A to a low score of 3.4 for system C, trial 3 (p < 0.0001). As expected, given the correlations to global satisfaction rating, system A also received the best responses regarding frequency of technical problems, ability of the help line to address those problems, and user-friendliness of the Web site. Furthermore, system C as used in trial 3, which received the lowest global satisfaction rating, also had the lowest scores on individual survey items pertaining to the frequency with which there were problems that required a call to the help line, the number of technical problems that required a replacement e-diary, and the ease with which data uploaded to the central data management Web site could be printed.
Conclusions
These results have a number of implications for the use of e-diary technology in collecting patient-reported data as part of clinical trials. First, a PDA device that works properly and is accompanied by high-quality technical support may be the most important feature of an e-diary system. Technical issues, such as problems with data transfer or with viewing data on the Web site, could potentially limit the utility of an e-diary system by making e-diaries appear to be more cumbersome than helpful. Accordingly, the results of this survey suggest that some key features of an appropriate system for use in a clinical trial include reducing the need for help line calls (e.g., through a more comprehensive user's manual), low potential for loss of patient data input, reduced number of technical problems that are difficult to resolve (such as those requiring the patient to receive a replacement PDA device), and reliable help line support able to fully address problems. In addition, the e-diary Web site is an essential tool for site coordinators in data management of a large clinical trial. Thus, any e-diary system under consideration should provide a wellorganized Web site layout that enables easy navigation and patient data management.
A finding from the current survey was that the global satisfaction ratings differed significantly among the three e-diary systems. Furthermore, differences among the systems were observed for a number of the issues discussed earlier. Another finding was that the global satisfaction rating did not significantly correlate with the patient age group participating in the trial, suggesting that young and elderly patients alike are willing to use the e-diary system. Importantly, because survey items such as previous e-diary experience or years of job experience did not correlate with the global satisfaction rating, differences among the three systems were not because of site coordinator background characteristics. Thus, the e-diary system chosen for a clinical trial should be selected with care.
While this survey provided valuable insight, it also had inherent limitations. One major limitation of this survey was the fact that the different e-diary systems under investigation were utilized differently in the four clinical trials employing them (i.e., not all parameters were assessed across studies). This difference in utilization may have influenced the differences seen in individual ratings. For example, although the same e-diary was used in trials 3 and 4 (system C), mean global satisfaction ratings (3.4 and 5.3, respectively) and individual survey item ratings were substantially lower in trial 3 than in trial 4. Therefore, it is possible that the manner in which the e-diary was utilized in trial 3, rather than the e-diary itself, may account for the low ratings. This limitation was taken into account during the design of the current analysis and, anticipating that the variation in the type of data collected would increase substantially if surveys were sent to site coordinators in clinical trials in other therapeutic areas (pain, asthma, etc.), the analysis was limited to diabetes studies.
Another potential limitation of this survey is the relatively low response rate of 44%. This was not entirely unexpected, given the length of the survey (requiring 15 to 20 minutes to complete), for very busy site coordinators. However, because no information is available on the background characteristics of the full sample versus those who responded, responder bias cannot be ruled out. Despite these limitations, this survey of site coordinators clearly highlights issues that need to be considered in selecting an e-diary for use in clinical trials, including the importance of minimizing technical issues with devices, assessing a vendor's help line capabilities, and choosing an e-diary system with an efficient and userfriendly Web site. Additional research will help to further clarify which types of data are best suited for e-diary collection in diabetes trials (e.g., blood glucose, hypoglycemic events, food intake, activity levels, and quality of life) or any other specific therapeutic area.
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We have used several e-diaries in different metabolism clinical trials. We would like to ask for your cooperation at this time to recall your knowledge and experience regarding the most recent e-diary you have worked with.
Please take a few moments to share your experiences with us as well as your thoughts on the patients' perspectives. Your feedback will be highly valuable to us in evaluating the uses of e-diaries for future clinical studies.
In answering each question, please put a check mark (√) in the box alongside the answer that best describes your experience. 
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